TENecteplase in Central Retinal Artery Occlusion (TEN-CRAOS): a prospective, randomized-controlled, double-dummy, double-blind phase 3 multi-centre trial of TNK 0.25mg/kg+placebo vs. ASA+placebo (2 arms with 1:1 block randomization)
Journal article published in 2020 by
A. H. Aamodt 
,
O. Jorstad,
K. L. Kraglund,
E. C. Sandset,
P. Vanacker,
S. Murphy,
J. Krohn,
E. Rodahl,
T. Bek,
M. Kurz,
S. H. Johnsen,
M. Mazya,
P. Ylikotila,
I. C. Olsen,
M. Moe
and other authors.
,
O. Jorstad,
K. L. Kraglund,
E. C. Sandset,
P. Vanacker,
S. Murphy,
J. Krohn,
E. Rodahl,
T. Bek,
M. Kurz,
S. H. Johnsen,
M. Mazya,
P. Ylikotila,
I. C. Olsen,
M. Moe
and other authors.
